Mechanistically, cancer cells secret interleukin 1β (IL1β) to activate the nuclear factor kappa B (NF-κB)/p65 pathway in SCs, thereby increasing the production of interleukin 6 (IL6) from SCs. The gene discussed is IL6; the disease is cancer.